PBM
ARDX icon

Propel Bio Management’s Ardelyx ARDX Stock Holding History

Propel Bio Management’s Portfolio ARDX Stock Details ARDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-950,947
Closed -$4.82M – 19
2024
Q4 		$4.82M Sell
950,947
-120,000
-11% -$663K 4.79% 9
2024
Q3 		$7.38M Buy
1,070,947
+146,364
+16% +$864K 4.28% 9
2024
Q2 		$6.85M Buy
924,583
+330,409
+56% +$2.32M 4.44% 9
2024
Q1 		$4.34M Hold
594,174
– – 2.52% 11
2023
Q4 		$3.68M Buy
+594,174
New +$2.67M 3.05% 10

Other funds holding ARDX

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Propel Bio Management's ARDX Position: Q1 2025 in Review

Propel Bio Management sold out of Ardelyx (ARDX) in Q1 2025, closing a stake of 950,947 shares — an estimated $4.82M sold.

Propel Bio Management first reported a position in ARDX in Q4 2023 and held it in 5 quarters. The position peaked at $7.38M in Q3 2024. 221 funds tracked by Wall St. Rank hold ARDX as of Q1 2025.

  • Propel Bio Management reported no remaining Ardelyx position as of Q1 2025 after selling out during the quarter.
  • Propel Bio Management sold 950,947 Ardelyx shares in Q1 2025, an estimated $4.82M.
  • Propel Bio Management first reported a position in Ardelyx in Q4 2023 and held it in 5 quarters.
  • Propel Bio Management's Ardelyx position peaked at $7.38M in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Ardelyx as of Q1 2025.

Based on Propel Bio Management's 13F filing for Q1 2025, filed 15 May 2025.